Reagent Lease – Automated Molecular Diagnostic System for Molecular Testing

The contract pertains to the lease of reagents for an automated molecular diagnostic system used in molecular testing. Shared Health Inc., a federal agency under the Government of Canada, is the coordinating entity seeking this product. The request identifies a single intended supplier, believed to be the only capable provider of the product, and the purpose of the solicitation is to confirm the absence of competition rather than to pre-qualify suppliers for a competitive procurement. Responses submitted will not be binding, and all costs associated with responding are the responsibility of the respondent. The solicitation, numbered REC-LB-CL-0027-SH, was posted on January 12, 2026, with a response deadline of January 21, 2026. Interested parties can access bidding documents through the Merx system, though fees may apply for document retrieval. The point of contact for this solicitation is Jessie Smilianov, the Contracting Authority, available by email and phone for any inquiries. The request emphasizes that this process is specific to this product and supplier and does not constitute a competitive bidding process.